title: Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer.
authors.forename: Andrea R
authors.initials: AR
authors.lastname: Hagemann
authors.forename: Israel
authors.initials: I
authors.lastname: Zighelboim
authors.forename: Anthony O
authors.initials: AO
authors.lastname: Odibo
authors.forename: Janet S
authors.initials: JS
authors.lastname: Rader
authors.forename: David G
authors.initials: DG
authors.lastname: Mutch
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Powell
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism / Q000628:therapy*; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D003663:Decision Trees; D004965:Estrogen Antagonists / Q000191:economics* / Q000627:therapeutic use; D005260:Female; D017273:Goserelin / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D010535:Laparoscopy / Q000191:economics*; D010052:Ovariectomy / Q000191:economics / Q000379:methods; D017697:Premenopause; D019057:Quality-Adjusted Life Years; D011960:Receptors, Estrogen / Q000378:metabolism
chemical_list: D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D017273:Goserelin